Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peach

Showing results (251-260 of 277) with videos related to

Pageof 28
Sort By:
Nature Structural Biology|July 1, 1997
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28W J Metzler, J Bajorath, W Fenderson, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Characterization and targeting of the endosomal signaling of the gastrin releasing peptide receptor in pruritusJeffri Retamal Santibañez, Diana Bok, Shavonne Teng, et al.
Journal of Clinical Pharmacology|April 12, 2017
Results From the First-in-Human Study With Ozanimod, a Novel, Selective Sphingosine-1-Phosphate Receptor ModulatorJonathan Q Tran, Jeffrey P Hartung, Robert J Peach, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Discovery of a sulfotyrosine-motif in the human TrkB extracellular domain required for agonist activationDavid C Briggs, Ryan T Duffy, Sarah Ateaque, et al.
British Journal of Pharmacology|March 19, 2016
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activityF L Scott, B Clemons, J Brooks, et al.
Rheumatology (Oxford, England)|January 30, 2023
The incidence of Kawasaki disease using hospital admissions data for England 2006-2021Myron Odingo, Megan Rutter, Jonathan Bowley, et al.
Nutrients|March 13, 2025
Association of Overnight Fasting Duration and Meal Frequency with Glucose and Lipid Metabolism During Pregnancy: A Cross-Sectional StudyKeiko Nakano, Moeko Tanaka, Nao Nishihara, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2016
Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitisE S Dellon, L L Higgins, R Beitia, et al.
Biochemical Pharmacology|April 11, 2017
Real-time analysis of the binding of fluorescent VEGF<sub>165</sub>a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexesLaura E Kilpatrick, Rachel Friedman-Ohana, Diana C Alcobia, et al.
The Journal of Clinical Investigation|November 26, 2024
Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain modelsChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Pageof 28

Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
Nature Structural Biology|July 1, 1997
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28W J Metzler, J Bajorath, W Fenderson, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Characterization and targeting of the endosomal signaling of the gastrin releasing peptide receptor in pruritusJeffri Retamal Santibañez, Diana Bok, Shavonne Teng, et al.
Journal of Clinical Pharmacology|April 12, 2017
Results From the First-in-Human Study With Ozanimod, a Novel, Selective Sphingosine-1-Phosphate Receptor ModulatorJonathan Q Tran, Jeffrey P Hartung, Robert J Peach, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Discovery of a sulfotyrosine-motif in the human TrkB extracellular domain required for agonist activationDavid C Briggs, Ryan T Duffy, Sarah Ateaque, et al.
British Journal of Pharmacology|March 19, 2016
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activityF L Scott, B Clemons, J Brooks, et al.
Rheumatology (Oxford, England)|January 30, 2023
The incidence of Kawasaki disease using hospital admissions data for England 2006-2021Myron Odingo, Megan Rutter, Jonathan Bowley, et al.
Nutrients|March 13, 2025
Association of Overnight Fasting Duration and Meal Frequency with Glucose and Lipid Metabolism During Pregnancy: A Cross-Sectional StudyKeiko Nakano, Moeko Tanaka, Nao Nishihara, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2016
Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitisE S Dellon, L L Higgins, R Beitia, et al.
Biochemical Pharmacology|April 11, 2017
Real-time analysis of the binding of fluorescent VEGF<sub>165</sub>a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexesLaura E Kilpatrick, Rachel Friedman-Ohana, Diana C Alcobia, et al.
The Journal of Clinical Investigation|November 26, 2024
Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain modelsChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Pageof 28